- Home
- MX vs PMVP Comparison
MX vs PMVP Comparison
Compare MX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | PMVP |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.8M | 68.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MX | PMVP |
|---|---|---|
| Price | $2.95 | $1.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.75 | $5.00 |
| AVG Volume (30 Days) | ★ 561.7K | 271.7K |
| Earning Date | 11-03-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $224,755,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.62 | N/A |
| 52 Week Low | $2.18 | $0.81 |
| 52 Week High | $5.16 | $1.84 |
Technical Indicators
Market Signals| Indicator | MX | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 47.48 |
| Support Level | $2.88 | $1.14 |
| Resistance Level | $3.09 | $1.31 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 85.37 | 53.57 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.